SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is fueling market optimism as strong Azure growth and AI-driven cloud demand help the company beat quarterly expectations while maintaining disciplined capital expenditure guidance. Investors are closely monitoring the shift toward enterprise AI monetization, with the community actively debating whether this resilience signals a broader rotation back into high-quality software stocks.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the unexpected announcement that ANKTIVA has received marketing authorization in the UAE for multiple bladder and lung cancer indications, fueling community speculation about further global expansion and a potential challenge to short sellers. Investors are actively discussing the significance of this international milestone as a sign of commercial momentum while closely tracking the stock's price volatility leading into upcoming quarterly earnings.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing significant selling pressure as investors react to a post-earnings miss and concerns over ballooning capital expenditures driven by aggressive AI infrastructure spending. Community sentiment is deeply divided, with many traders expressing frustration over the company's fiscal discipline and long-term spending outlook, while long-term investors weigh the potential for future returns against the immediate volatility.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is currently trending as investors grapple with sharp market volatility, fueled by concerns over AI infrastructure spending, rising bond yields, and broader geopolitical tensions in the Middle East. The community is actively debating whether the recent pullback represents a buying opportunity in tech or a deeper structural correction, with many traders closely watching after-hours fluctuations and earnings catalysts for signs of stabilization.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing significant volatility as investors weigh the impact of heavy institutional selling and margin liquidations against a backdrop of surging AI-driven demand for memory chips. The community is actively debating whether this represents an overextended pullback in a long-term AI supercycle or a broader cyclical downturn, with many traders closely monitoring sentiment in the Korean chip sector for potential signs of stabilization.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood investors are closely watching the upcoming earnings report, with community sentiment divided between excitement over record revenue metrics and growing frustration over recent technical app failures and volatility. While some see the stock as a long-term disruptor, others are skeptical about its sustainability, sparking intense debates between bullish traders expecting a post-earnings rally and bearish voices wary of the broader market environment.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant investor focus as the market scrutinizes its ability to maintain robust ABS deal activity despite a volatile macroeconomic backdrop. The community is actively debating the company's valuation gap and institutional potential, with many investors weighing the stock's fundamental strength against ongoing concerns regarding interest rate sentiment and broader fintech sector pressure.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc shares are facing significant volatility as investors weigh a disappointing financial outlook against strong institutional accumulation and aggressive short interest. While the company is actively expanding its insurance-covered BetterHelp segment and building out its integrated care platform, the market remains divided between those betting on a long-term turnaround and traders skeptical of its near-term margin and growth trajectory.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to heightened speculation surrounding a potential buyout or partnership as institutional interest builds ahead of key clinical readouts, including the upcoming VK2735 maintenance dosing study results. While the community remains divided over management's communication and recent insider activity, bulls are pinning their hopes on pipeline progress to validate the stock as a best-in-class competitor in the rapidly expanding obesity market.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

The iShares 20+ Year Treasury Bond ETF is trending as investors grapple with shifting rate hike expectations and heightened geopolitical uncertainty in the Middle East, leading to significant volatility in bond yields. Community discourse is heavily focused on the bond market acting as a barometer for broader economic stress, with traders debating whether persistent inflation and geopolitical risks will continue to pressure long-duration assets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
